NASDAQ:CNTX

Context Therapeutics Stock Forecast

etoro logo Buy CNTX
*Your capital is at risk
$0.599
+0.0385 (+6.88%)
At Close: Jun 26, 2026
AI Analysis AI Analysis of CNTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CNTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Strong day for Context Therapeutics Inc. stock price on Friday rising 6.88% to $0.599
(Updated on Jun 26, 2026)

Sell candidate since Jun 02, 2026 Loss -75.27%

The Context Therapeutics Inc. stock price gained 6.88% on the last trading day (Friday, 26th Jun 2026), rising from $0.560 to $0.599. During the last trading day the stock fluctuated 8.59% from a day low at $0.568 to a day high of $0.617. The price has fallen in 7 of the last 10 days and is down by -57.85% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $2.74 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.532 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -41.75% during the next 3 months and, with a 90% probability hold a price between $0.310 and $1.40 at the end of this 3-month period.

CNTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 6.88%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Context Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.607 and $1.81. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Context Therapeutics Inc. stock

Context Therapeutics Inc. finds support from accumulated volume at $0.576 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0488 between high and low, or 8.59%. For the last week, the stock has had daily average volatility of 13.49%.

Context Therapeutics Inc. is oversold on RSI14 (7). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNTX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Context Therapeutics Inc. to open at $0.595, and during the day (based on 14 day Average True Range), to move between $0.518 and $0.679, which gives a possible trading interval of +/-$0.161 (+/-31.15%) up or down from last closing price. If Context Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 31.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.600 (0.25%) than the support at $0.576 (3.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Context Therapeutics Inc. stock A Buy?

Context Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.777 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $0.595 ( 0.635%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CNTX Performance

Trading levels for CNTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.644 7.52%
R2 0.625 4.40%
R1 0.613 2.48%
Price 0.599
S1 0.576 -3.75%
S2 0.565 -5.67%
S3 0.546 -8.79%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.679 13.47%
R2 0.650 8.65%
R1 0.600 0.251%
Price 0.599
S1 0.576 -3.76%
S2 0.560 -6.43%
S3 0 -

FAQ

What is the symbol for Context Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Context Therapeutics Inc. is CNTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Context Therapeutics Inc. Stock?
Context Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Context Therapeutics Inc. Stock?
Context Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Context Therapeutics Inc. Stock.

What's the current price of Context Therapeutics Inc. Stock?
As of the end of day on the Jun 26, 2026, the price of an Context Therapeutics Inc. (CNTX) share was $0.599.

What is the 52-week high and low for Context Therapeutics Inc. Stock?
The 52-week high for Context Therapeutics Inc. Stock is $3.62 and the 52-week low is $0.545.

What is the market capitalization of Context Therapeutics Inc. Stock?
As of the Jun 26, 2026, the market capitalization of Context Therapeutics Inc. is 53.29M.

When is the next earnings date for Context Therapeutics Inc.?
The upcoming earnings date for Context Therapeutics Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT CONTEXT THERAPEUTICS INC.
Context Therapeutics
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also dev...
GOLDEN STAR
Ticker Change Signal Date
JLL
$299.78
5.10% Jun 24
X
XMAX
$8.34
5.40% Jun 24
TWI
$7.56
6.08% Jun 22
IAC
$42.63
5.08% Jun 12
DHI
$146.71
13.35% Jun 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE